On December 2, 2016, Health Canada released its updated guidelines for biosimilar biologic drug submissions. The document will provide guidance ... Read More
Events
06
Dec2016
02
Dec2016
As a first step to framework modernization, the Patented Medicines Prices Review Board (PMPRB) is undertaking major consultations regarding possible ... Read More
01
Dec2016
Effective December 1, 2016, all new Special Authorization requests for the treatment of Moderately to Severely Active Crohn's Disease and ... Read More
28
Nov2016
Ontario Public Drug Programs Funds New Indications for INFLECTRA™ (infliximab)
/ Ontario, pCPA, What's New
Effective November 30, 2016, the Ontario Public Drug Programs will begin funding INFLECTRA™ (infliximab) as a limited use benefit for ... Read More
23
Nov2016
The Patented Medicine Prices Review Board (PMPRB) announced the reappointment of Dr. Mitchell Levine of Hamilton, Ontario as Vice-chairperson of ... Read More
09
Nov2016
Owing to new developments and growing stakeholder interest, PDCI and H3 have now completed a second private payer PLA survey. ... Read More
31
Oct2016
The Canadian Association for Healthcare Reimbursement (CAHR) is holding a one-day event to explore a national approach to pharma policy ... Read More
20
Oct2016
INESSS Upcoming Meetings with Manufacturers – June 2017 “Liste des médicaments”
INESSS is offering an opportunity for in-person meetings to manufacturers ... Read More